tirzepatide phase 3 study results Once-weekly versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, trial π¨ HOT OFF THE PRESS:
Pay in 4 interest-free payments of $5.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 22 - Aug 27























